Fortrea (FTRE) Scheduled to Post Earnings on Friday

Fortrea (NASDAQ:FTRE – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Friday, November 8th. Analysts expect Fortrea to post earnings of $0.27 per share for the quarter. Fortrea has set its FY 2024 guidance at EPS.Individual that are interested in registering for the company’s earnings conference call [...]

featured-image

Fortrea ( NASDAQ:FTRE – Get Free Report ) is scheduled to post its quarterly earnings results before the market opens on Friday, November 8th. Analysts expect Fortrea to post earnings of $0.27 per share for the quarter.

Fortrea has set its FY 2024 guidance at EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link . Fortrea ( NASDAQ:FTRE – Get Free Report ) last posted its quarterly earnings data on Monday, August 12th.



The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.

10). Fortrea had a positive return on equity of 1.98% and a negative net margin of 10.

09%. The company had revenue of $662.40 million for the quarter, compared to analysts’ expectations of $689.

08 million. During the same quarter last year, the business posted $0.52 EPS.

The business’s quarterly revenue was down 8.6% on a year-over-year basis. On average, analysts expect Fortrea to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fortrea Stock Up 1.4 % Fortrea stock opened at $17.10 on Wednesday.

The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.

77. The company has a market capitalization of $1.53 billion, a P/E ratio of -5.

24, a P/E/G ratio of 2.71 and a beta of 0.70.

The firm has a 50 day moving average price of $20.00 and a 200-day moving average price of $24.47.

Fortrea has a twelve month low of $16.53 and a twelve month high of $41.02.

Analysts Set New Price Targets View Our Latest Stock Analysis on Fortrea Fortrea Company Profile ( Get Free Report ) Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.

Read More Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter ..